David Harpole, MD / Nicolas Girard, MD, PhD - Trials and Tribulations: Examining the Data for Perioperative Immunotherapeutic Approaches in Resectable NSCLC

Jacob Sands, MD / Luis Paz-Ares, MD, PhD - Leveraging Precise Targets to Elevate Outcomes: NSCLC Treatment Strategies for HER2-Directed ADCs

Jia Ruan, MD, PhD - Clinical Case Challenges in Frontline PTCL: Navigating the Landscape of CD30-Positive PTCL Treatment

Nikhil I. Khushalani, MD - Practical Guidance for Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: Using Immunotherapy Effectively in Clinical Practice

Christoph U. Correll, MD - Transforming the Treatment of Schizophrenia: Moving Beyond Anti-Dopaminergic Antipsychotics to Muscarinic Receptor Agonists

Evan S. Dellon, MD, MPH - In Case of Emergency: Ensuring Timely Recognition and Intervention in Patients With Eosinophilic Esophagitis

Jacob Sands, MD / Raffaele Califano, MD - Novel ADC Targets in Advanced NSCLC: Examining Emerging Strategies for TROP2-Directed ADCs

Juliana M. Kling, MD, MPH - Turning Down the Heat: Exploring Newly Approved and Emerging Nonhormonal Therapies for Menopause-Associated VMS

Christoph U. Correll, MD - Pathways to Hope: Emerging Therapies in Alzheimer’s Disease Psychosis

Stephanie A. Christenson, MD, MAS - ​Targeting Eosinophils for Fewer Exacerbations:​ The Future of Biologic Treatments in COPD Management

Joyce O'Shaughnessy, MD - Harnessing Immunotherapy for Early Breast Cancer Management: Neoadjuvant Updates in HR-Positive, HER2-Negative Disease

Ahmad Tarhini, MD, PhD - Adjuvant Approaches in High-Risk, Resectable Melanoma: A Practical Guide to Improving Outcomes With Immunotherapy-Based Regimens

David M. Miller, MD, PhD / Todd Schlesinger, MD - A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies

Vasu Divi, MD, MS - Neoadjuvant Immunotherapy for CSCC: Practical Considerations for Resectability, Patient Selection, and Treatment Optimization

Leonard B. Bacharier, MD - Highlighting the Use of Biologics in Pediatric Patients: Case Scenarios to Elevate Asthma Treatment

Mark Awad, MD, PhD - Advancing the Therapeutic Landscape of SCLC with B7-H3–Targeted Antibody-Drug Conjugates: Insights and Future Directions

Vibeke Strand, MD / April W. Armstrong, MD, MPH - A New Take on TYK2 Inhibitors: Bridging Gaps in Psoriatic Arthritis Management With Novel Targeted Therapies

Cecelia Damask, DO - Evidence-Based Approaches to Sequencing and Switching Biologic Therapies in Patients With CRSwNP and Comorbidities

Aditya Bardia, MD - From Theory to Practice: Enhancing Antibody-Drug Conjugate Integration in HER2-Low Advanced Breast Cancer

Rami Komrokji, MD - Navigating the First-Line Treatment Landscape of Anemia in Lower-Risk MDS: Translating the Latest Data to Practice